Menu

Back to Medication Guide

Naltrexone

Generic Name: Naltrexone

Brand Names: ReVia, Vivitrol

Naltrexone is an opioid antagonist used for alcohol use disorder and opioid use disorder. Blocks effects of opioids and reduces alcohol cravings.

PsychiatryAddiction MedicineSubstance Use

Drug Class

Opioid Antagonist

Pregnancy

Category C (oral); no adequate well-controlled studies in pregnant women. Animal studies have shown adverse effects on the fetus. Use only if the potential benefit justifies the potential risk to the fetus.

Available Forms

50 mg oral tablet, 380 mg/vial extended-release intramuscular suspension (Vivitrol)

Dosage Quick Reference

These are general dosage guidelines. Your doctor will determine the appropriate dose for your specific situation.

ConditionStarting DoseMaintenance Dose
Alcohol Dependence (oral)25 mg once daily for the first day to assess tolerability50 mg once daily
Alcohol Dependence (IM injection)380 mg IM into gluteal muscle once380 mg IM every 4 weeks, alternating buttocks
Opioid Dependence (oral)25 mg initially; patient must be opioid-free 7-10 days50 mg once daily (or 100 mg Mon/Wed, 150 mg Fri for supervised dosing)

Side Effects

Common Side Effects:

  • Nausea (most common initially)
  • Headache
  • Dizziness
  • Fatigue
  • Anxiety
  • Insomnia
  • Injection site reactions (IM form)

Serious Side Effects:

  • Hepatotoxicity
  • Precipitated opioid withdrawal
  • Depression and suicidal ideation
  • Eosinophilic pneumonia (rare)

Drug Interactions

  • Opioid analgesics (morphine, oxycodone, hydrocodone, fentanyl): Naltrexone blocks opioid receptors and will precipitate acute withdrawal in opioid-dependent patients. Patients must be opioid-free for at least 7 to 10 days before starting naltrexone.
  • Opioid-containing medications (cough suppressants with codeine, antidiarrheals with loperamide at high doses): The analgesic and antitussive effects of opioid-containing products will be diminished or blocked entirely.
  • Thioridazine: Concurrent use may cause increased lethargy and somnolence. Avoid combination when possible.
  • Disulfiram: Both are used for alcohol dependence but concurrent use may increase hepatotoxicity risk. Monitor liver function if combined.
  • Hepatotoxic medications (acetaminophen in high doses, certain statins): Naltrexone carries a boxed warning for hepatotoxicity at high doses; avoid combining with other hepatotoxic agents.

Additional Information

Naltrexone is an opioid antagonist used to treat alcohol use disorder and prevent relapse in opioid use disorder after detoxification. By blocking opioid receptors, it reduces the rewarding effects of alcohol and opioids, helping patients maintain abstinence.

Mechanism of Action

Naltrexone competitively binds to opioid receptors (primarily mu, with some kappa and delta activity):

  • In opioid use disorder: Blocks the euphoric effects of opioids, reducing motivation to use
  • In alcohol use disorder: Blocks endogenous opioid release triggered by alcohol, reducing the pleasurable effects and cravings

Unlike methadone or buprenorphine, naltrexone has no agonist activity and does not produce euphoria, physical dependence, or tolerance.

Available Formulations

  • Oral tablets: 50 mg (daily dosing)
  • Extended-release injectable suspension (Vivitrol): 380 mg IM every 4 weeks

The injectable form improves compliance by eliminating daily dosing decisions.

Medical Uses

FDA-Approved Indications:

  • Alcohol use disorder (both formulations)
  • Prevention of relapse to opioid dependence after opioid detoxification (both formulations)

Naltrexone is most effective as part of a comprehensive treatment program including counseling and psychosocial support.

Dosing Guidelines

Alcohol Use Disorder:

  • Oral: 50 mg once daily
  • IM: 380 mg every 4 weeks (gluteal injection, alternating sides)

Opioid Use Disorder:

  • Oral: 50 mg once daily (or alternative regimens: 100 mg Monday/Wednesday, 150 mg Friday)
  • IM: 380 mg every 4 weeks

Critical Requirement: Patient must be opioid-free for 7-10 days before starting naltrexone to avoid precipitated withdrawal. Urine drug screen and/or naloxone challenge recommended.

Important Safety Information

Black Box Warning (Injectable):

  • Risk of hepatotoxicity
  • Vulnerable to opioid overdose after discontinuation due to reduced tolerance

Contraindications:

  • Current opioid use or dependence
  • Acute opioid withdrawal
  • Positive urine screen for opioids
  • Acute hepatitis or liver failure
  • Prior hypersensitivity to naltrexone

Warnings and Precautions:

  • Hepatotoxicity: Monitor liver function
  • Precipitation of opioid withdrawal if opioids present
  • Patients should carry wallet card indicating naltrexone use
  • Large opioid doses to overcome blockade can cause fatal overdose
  • Depression and suicidality: Monitor closely

Drug Interactions

  • Opioid analgesics: Blocked by naltrexone; higher doses needed for pain control (dangerous)
  • Opioid-containing products: Avoid cough syrups, antidiarrheals with opioids
  • Thioridazine: Increased lethargy and somnolence

Special Populations

  • Hepatic Impairment: Use with caution; monitor liver function
  • Renal Impairment: Use with caution in severe impairment
  • Pregnancy: Use only if benefit outweighs risk
  • Elderly: No specific adjustments but increased monitoring recommended

Overdose Management

Patients on naltrexone who require emergency analgesia present challenges:

  • Higher opioid doses needed (with respiratory monitoring)
  • Regional anesthesia, non-opioid analgesics, and general anesthesia preferred
  • Consult pain management specialists

Frequently Asked Questions

Unlike disulfiram, you do not need to be completely abstinent from alcohol before starting naltrexone. However, you should not be physically dependent on opioids when initiating therapy. Naltrexone works by reducing the rewarding effects of alcohol, making it easier to cut down or stop.
Naltrexone blocks opioid receptors, so standard doses of opioid medications will not produce the expected pain-relieving or euphoric effects. Attempting to override the blockade with high doses of opioids is extremely dangerous and can lead to respiratory depression, coma, or death.
Treatment duration varies by individual. Many clinicians recommend at least 3 to 6 months, and some patients benefit from longer-term treatment. Your doctor will help determine the best duration based on your progress and recovery goals.
At the recommended 50 mg daily dose, clinically significant liver injury is rare. However, naltrexone does carry a boxed warning for hepatotoxicity seen at higher doses in early research. Your doctor will check liver function before starting and periodically during treatment.
Oral naltrexone is taken daily as a tablet and requires consistent adherence. Vivitrol is a once-monthly intramuscular injection that provides sustained drug levels, which can be beneficial for patients who struggle with daily pill adherence. Both contain the same active ingredient.

Questions to Ask Your Doctor

Consider discussing these topics at your next appointment:

  • Should I carry a medical alert card indicating I am taking an opioid antagonist?
  • How will my pain be managed in an emergency if I need surgery while on naltrexone?
  • What liver function tests should be done before and during treatment?
  • Is the monthly Vivitrol injection a better option for me compared to daily oral tablets?
  • Are there behavioral therapy programs I should combine with naltrexone treatment?

Medical Disclaimer: This information is for educational purposes only and should not be considered medical advice. Always consult with your healthcare provider before starting, stopping, or changing any medication. Your doctor can provide personalized recommendations based on your specific health condition and medical history.